Some preclinical studies have shown that in tumor models, anti-CD47 antibody treatment not only promoted the phagocytosis of cancer cells by macrophages, but also induced an antitumor cytotoxic T cell immune response [104]. The gene discussed is CD47; the disease is neoplasm.